Len Blavatnik

CIK 1326628 · last filed 2026-04-20

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.32B

Companies

6

Total Filings

15

Lifetime Open-Market Net

-$2.13B

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
WMG 10%+ Owner $28.46 $0 1 2026-04-20
IRON 10%+ Owner 3,558,426 $67.99 $241.94M $40.00M 2 2024-06-20
Day One Biopharmaceuticals, Inc. (DAWN) Delisted 11,453,868 $21.53 $246.60M $40.00M 1 2023-06-12
LYB 10%+ Owner 16,766,672 $64.58 $1.08B -$2.21B 8 2022-12-05
Neon Therapeutics, Inc. (NTGN) Delisted 2,752,480 -$2.76M 1 2020-03-25
Loxo Oncology, Inc. (LOXO) Delisted 10%+ Owner 1,368,339 $0 1 2014-08-06

Recent Filings · Page 2 of 2

15 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-02-17 LYB Sell (S) −1,968,900 -$188.25M EDGAR
2020-12-08 LYB Sell (S) −2,593,455 -$229.74M EDGAR
2020-03-25 Neon Therapeutics, Inc. (NTGN) Delisted Sell (S) −1,260,220 -$2.76M EDGAR
2014-08-06 Loxo Oncology, Inc. (LOXO) Delisted Conv (C) +5,473,356 $0 EDGAR
2007-05-08 Other (J) +3,531,089 $0
Showing 1115 of 15
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.